Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414128 | SCV000491470 | uncertain significance | not specified | 2016-11-30 | criteria provided, single submitter | clinical testing | The L47F variant in the ABCD4 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The L47F variant was not observed with any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The L47F variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, we interpret L47F as a variant of uncertain significance. |
Invitae | RCV001034174 | SCV001197504 | likely benign | Methylmalonic acidemia with homocystinuria, type cblJ | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV001034174 | SCV001251917 | likely benign | Methylmalonic acidemia with homocystinuria, type cblJ | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002523924 | SCV003691377 | likely benign | Inborn genetic diseases | 2021-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |